Mutations of the human E-cadherin (CDH1) gene

Human Mutation

Volumn 12, Issue 4, 1998, Pages 226-237

  Berx, Geert ^a   Becker, Karl Friedrich ^b,c   Höfler, Heinz ^b,c   Van Roy, Frans ^a  

^a GHENT UNIVERSITY   (Belgium)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Breast cancer; E cadherin gene; Gastric cancer; Germline mutations; Somatic mutations; Tumor suppressor

Indexed keywords

ALPHA ACTININ; BETA CATENIN; F ACTIN; PLAKOGLOBIN; UVOMORULIN;

BREAST CANCER; CELL ADHESION; GENE DELETION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SOMATIC MUTATION; STOMACH CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CADHERINS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; STOMACH NEOPLASMS;

EID: 0031686121     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D     Document Type: Review

References (71)

1. Aberle H, Schwartz H, Kemler R (1996) Cadherin-catenin complex: Protein interactions and their implications for cadherin function. J Cell Biochem 61:514-523.
2. Barth AIM, Nathke IS, Nelson WJ (1997) Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 9:683-690.
3. Beaudet AL, Tsui L-C (1993) A suggested nomenclature for designating mutations. Hum Mutat 2:245-248.
4. Becker I, Becker KF, Röhrl MH, Minkus O, Schütze K, Höfler H (1996) Single-cell mutation analysis of tumors from stained histologic slides. Lab Invest 75:801-807.
5. Becker KF, Höfler H (1995) Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 87:1082-1084.
6. Becker K-F, Atkinson MJ, Reich U, Huang H-H, Nekarda H, Stewert JR, Höfler H (1993) Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet 2 803-804.
7. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Stewert JR, Höfler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54.3845-3852.
8. Becker KF, Reich U, Schott C, Höfler H (1995) Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 96:739-740.
9. Becker KF, Reich U, Schott C, Becker I, Berx G, van Roy F, Hofler H (1998) Identification of eleven novel tumor-associated E-cadherin mutations. Hum Mutat (in press).
10. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638-642.
11. Bergerheim US, Kunimi K, Collins VP, Ekman P (1991) Deletion mapping of chromosome 8, 10, and 16 in human prostatic carcinoma. Gene Chromosom Cancer 3.215-220.
12. Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJG, van Bokhoven A, van Roy F (1995a) Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26.281-289.
13. Berx G, Cleton-Jansen A-M, Nollet F, de Leeuw WJF, van de Vijver MJ, Cornelisse C, van Roy F (1995b) E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115.
14. Berx G, Cleton-Jansen A-M, Strumane K, de Leeuw WJF, Nollet F, van Roy FM, Cornelisse C (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925.
15. Berx G, Nollet F, Strumane K, van Roy F (1997) An efficient and reliable multiplex PCR/SSCP mutation analysis test applied to the human E-cadherin gene. Hum Mutat 9:567-574.
16. Bracke ME, van Roy FM, Mareel MM (1996) The E-cadherin/catenin complex in invasion and metastasis. In Günthert U, Birchmeier W (eds): Attempts to Understand Metastasis Formation. Vol I. Berlin: Springer-Verlag, pp 123-161.
17. Bussemakers MJ, van-Bokhoven A, Mees SG, Kemler R, Schalken JA (1993) Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep 17:123-128.
18. Callen DF, Eyre H, Lane S, Shen Y, Hansmann I, Spinner N, Zackai E, McDonaldmcginn D, Schuffenhauer S, Wauters J, Vanthienen MN, van Roy B, Sutherland GR, Haan EA (1993) High resolution mapping of interstitial long arm deletions of chromosome-16 - relationship to phenotype. J Med Genet 30:828-832.
19. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
20. Cleton-Jansen A-M, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ (1994) At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Gene Chromosom Cancer 9:101-107.
21. Cowin P (1994) Unraveling the cytoplasmic interactions of the cadherin superfamily. Proc Natl Acad Sci USA 91:10759-10761.
22. Damsky CH, Richa J, Solter D, Knudsen K, Buck CA (1983) Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 34.455-466.
23. de Leeuw WJF, Berx G, Vos CBJ, Peterse JL, van de Vijver MJ, Litvinov S, van Roy FM, Cornelisse CJ, Cleton-Jansen A-M (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183:404-411.
24. Fagotto F, Funayama N, Gluck U, Gumbiner BM (1996) Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. J Cell Biol 132 1105-1114.
25. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185.
26. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142:987-993.
27. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199.
28. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402-405.
29. Gumbiner BM (1997) Carcinogenesis: A balance between beta-catenin and APC. Curr Biol 7:R443-R446.
30. Heasman J, Crawford A, Goldstone K, Garnerhamrick P, Gumbiner B, McCrea P, Kintner C, Noro CY, Wylie C (1994) Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 79.791-803.
31. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
32. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R (1996) Nuclear localization of β-catenin by interaction with transcription factor LEF-I. Mech Dev 59:3-10.
33. Ilyas M, Tomlinson IPM, Rowan A, Pignatelli M, Bodmer WF (1997) β-Catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94:10330-10334.
34. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S (1994) Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 85.1035-1039.
35. Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, Hirohashi S (1997) The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71:355-359.
36. Kashiwaba M, Tamura G, Suzuki Y, Maesawa C, Ogasawara S, Sakata K, Satodate R (1995) Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res 86:1054-1059.
37. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I (1994) Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 69:580-585.
38. Knudson AG (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
39. Larue L, Ohsugi M, Hirchenhain J, Kemler R (1994) E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 91:8263-8267-
40. Li C, Berx G, Larsson C, Auer G, Aspenblad U, Pan Y, Sundelin B, Ekman M, van Roy F, Bergerheim USR (1998) Lack of somatic E-cadherin mutations in prostate cancer and localization of distinct deleted regions on chromosome 16q associated with metastases. (Submitted for publication.)
41. Mansouri A, Spurr N, Goodfellow PN, Kemler R (1988) Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 38:67-71.
42. Mareel M, Berx G, Van Roy F, Bracke M (1996) The cadherin/catenin complex: A target for antiinvasive therapy? J Cell Biochem 61:524-530.
43. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 m human cancers. Nature Med 1:686-692.
44. Miller JR, Moon RT (1996) Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Gene Dev 10:2527-2539.
45. Moll R, Mitze M, Frixen UH, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143.1731-1742.
46. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1789.
47. Muta H, Noguchi M, Kanal Y, Ochiai A, Nawata H, Hirohashi S (1996) E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 87:843-848.
48. Natt E, Magenis RE, Zimmer J, Mansouri A, Scherer G (1989) Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet Cell Genet 50:145-148.
49. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S (1994) E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91:1858-1862.
50. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene Oncogene 8:1063-1067.
51. 2+ binding site of uvomorulin abolish the adhesive function. Cell 63.1033-1038.
52. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER (1995) Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 11:1319-1326.
53. Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta Rev Cancer 1332:F127-F147.
54. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR (1993) Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169:245-250.
55. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z (1994) Identification of a new catenin: The tyrosine kinase substrate p120(cas) associates with E-cadherin complexes. Mol Cell Biol 14:8333-8342.
56. Riethmacher D, Brinkmann V, Birchmeier C (1995) A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc Natl Acad Sci USA 92:855-859.
57. Risinger JI, Berchuck A, Kohler MF, Boyd J (1994) Mutations of the E-cadherin gene m human gynecologic cancers. Nature Genet 7:98-102.
58. Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59.423-450.
59. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792.
60. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
61. Soares P, Berx G, van Roy F, Sobrinho-Simoes M (1997) E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 70.32-38.
62. Su LK, Vogelstein B, Kinzler KW (1993) Association of the APC tumor suppressor protein with catenins. Science 262:1734-1737.
63. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455.
64. Takeichi M (1995) Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619-627.
65. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R (1996) Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 87 1153-1159.
66. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ, Isaacs WB (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109.
67. Vermeulen S, Van Marck V, Van Hoorde L, van Roy F, Bracke M, Mareel M (1996) Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol Res Pract 192:694-707.
68. Vleminckx K, Vakaet Jr L, Marcel M, Fiers W, Van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119.
69. Vos CBJ, Cleton-Jansen A-M, Berx G, de Leeuw WJF, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis. Br J Cancer 76:1131-1133.
70. Wheelock MJ, Buch CA, Bechtol KB, Damsky CH (1987) Soluble 80-kD fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 34:187-202.
71. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92:7416-7419.